Global Drug Eluting Stents (DES) Market Research Report 2025(Status and Outlook)

Report Overview

Drug Eluting Stents (DES) are medical devices used in the treatment of coronary artery disease. These stents are designed to prevent restenosis, which is the re-narrowing of the arteries after a stent has been inserted. DES are coated with medication that is slowly released into the surrounding tissue, helping to reduce inflammation and inhibit cell proliferation. This innovative technology has significantly improved the outcomes of patients undergoing coronary artery stenting procedures by reducing the need for repeat interventions.

The market for Drug Eluting Stents (DES) is experiencing steady growth due to several key market trends and drivers. One major trend is the increasing prevalence of coronary artery disease worldwide, driven by factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits. As a result, there is a growing demand for minimally invasive treatment options like DES. Additionally, advancements in stent design and drug coatings are improving the efficacy and safety of DES, further driving market growth. Moreover, the rising adoption of DES in emerging markets, along with increasing investments in healthcare infrastructure, is expected to fuel market expansion. At the same time, ongoing research and development efforts aimed at enhancing the performance of DES are likely to open up new opportunities for market players.

The global Drug Eluting Stents (DES) market size was estimated at USD 1563 million in 2024 and is projected to reach USD 2808.39 million by 2033, exhibiting a CAGR of 7.60% during the forecast period.

This report provides a deep insight into the global Drug Eluting Stents (DES) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc. In terms of regional markets, the report details the market space and development potential of each market segment in North America, Europe, Asia Pacific, South America, the Middle East and Africa, as well as the competitive landscape of major players, etc

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Eluting Stents (DES) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Eluting Stents (DES) market in any manner.

Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Vascular

Advantec Vascular

B.Braun Melsengen AG

Biosensors

Biotronik

Blue Medical

Boston Scientific

DISA Vascular

Essen

Medtronic Vascular

MicroPort Medical

MIV Therapeutics

Orbusneich

Promed Medical

Relisys Medical

Reva Medical

Sahajanand

Sino Medical

Sorin

Terumo Medical

Market Segmentation (by Type)

Cobalt-chromium Alloy Stents

Magnesium Alloy Stents

Tyrosine Polycarbonate Stents

Nitinol Stents

Platinum Chromium Alloy Stents

Stainless Steel Stents

Other Materials

Market Segmentation (by Application)

Coronary Heart Disease

Clinical

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Drug Eluting Stents (DES) Market

Overview of the regional outlook of the Drug Eluting Stents (DES) Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Drug Eluting Stents (DES), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug Eluting Stents (DES)
1.2 Key Market Segments
1.2.1 Drug Eluting Stents (DES) Segment by Type
1.2.2 Drug Eluting Stents (DES) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Drug Eluting Stents (DES) Market Overview
2.1 Global Market Overview
2.1.1 Global Drug Eluting Stents (DES) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Drug Eluting Stents (DES) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Drug Eluting Stents (DES) Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Drug Eluting Stents (DES) Product Life Cycle
3.3 Global Drug Eluting Stents (DES) Sales by Manufacturers (2020-2025)
3.4 Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Drug Eluting Stents (DES) Manufacturing Sites, Area Served, Product Type
3.8 Drug Eluting Stents (DES) Market Competitive Situation and Trends
3.8.1 Drug Eluting Stents (DES) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug Eluting Stents (DES) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Drug Eluting Stents (DES) Industry Chain Analysis
4.1 Drug Eluting Stents (DES) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drug Eluting Stents (DES) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Drug Eluting Stents (DES) Market
5.7 ESG Ratings of Leading Companies
6 Drug Eluting Stents (DES) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
6.3 Global Drug Eluting Stents (DES) Market Size Market Share by Type (2020-2025)
6.4 Global Drug Eluting Stents (DES) Price by Type (2020-2025)
7 Drug Eluting Stents (DES) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Eluting Stents (DES) Market Sales by Application (2020-2025)
7.3 Global Drug Eluting Stents (DES) Market Size (M USD) by Application (2020-2025)
7.4 Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
8 Drug Eluting Stents (DES) Market Sales by Region
8.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.2 Global Drug Eluting Stents (DES) Sales Market Share by Region
8.2 Global Drug Eluting Stents (DES) Market Size by Region
8.2.1 Global Drug Eluting Stents (DES) Market Size by Region
8.2.2 Global Drug Eluting Stents (DES) Market Size Market Share by Region
8.3 North America
8.3.1 North America Drug Eluting Stents (DES) Sales by Country
8.3.2 North America Drug Eluting Stents (DES) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drug Eluting Stents (DES) Sales by Country
8.4.2 Europe Drug Eluting Stents (DES) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drug Eluting Stents (DES) Sales by Region
8.5.2 Asia Pacific Drug Eluting Stents (DES) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drug Eluting Stents (DES) Sales by Country
8.6.2 South America Drug Eluting Stents (DES) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Region
8.7.2 Middle East and Africa Drug Eluting Stents (DES) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Drug Eluting Stents (DES) Market Production by Region
9.1 Global Production of Drug Eluting Stents (DES) by Region(2020-2025)
9.2 Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
9.3 Global Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug Eluting Stents (DES) Production
9.4.1 North America Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.4.2 North America Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug Eluting Stents (DES) Production
9.5.1 Europe Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.5.2 Europe Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug Eluting Stents (DES) Production (2020-2025)
9.6.1 Japan Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.6.2 Japan Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug Eluting Stents (DES) Production (2020-2025)
9.7.1 China Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.7.2 China Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Abbott Vascular
10.1.1 Abbott Vascular Basic Information
10.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Overview
10.1.3 Abbott Vascular Drug Eluting Stents (DES) Product Market Performance
10.1.4 Abbott Vascular Business Overview
10.1.5 Abbott Vascular SWOT Analysis
10.1.6 Abbott Vascular Recent Developments
10.2 Advantec Vascular
10.2.1 Advantec Vascular Basic Information
10.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Overview
10.2.3 Advantec Vascular Drug Eluting Stents (DES) Product Market Performance
10.2.4 Advantec Vascular Business Overview
10.2.5 Advantec Vascular SWOT Analysis
10.2.6 Advantec Vascular Recent Developments
10.3 B.Braun Melsengen AG
10.3.1 B.Braun Melsengen AG Basic Information
10.3.2 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
10.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Market Performance
10.3.4 B.Braun Melsengen AG Business Overview
10.3.5 B.Braun Melsengen AG SWOT Analysis
10.3.6 B.Braun Melsengen AG Recent Developments
10.4 Biosensors
10.4.1 Biosensors Basic Information
10.4.2 Biosensors Drug Eluting Stents (DES) Product Overview
10.4.3 Biosensors Drug Eluting Stents (DES) Product Market Performance
10.4.4 Biosensors Business Overview
10.4.5 Biosensors Recent Developments
10.5 Biotronik
10.5.1 Biotronik Basic Information
10.5.2 Biotronik Drug Eluting Stents (DES) Product Overview
10.5.3 Biotronik Drug Eluting Stents (DES) Product Market Performance
10.5.4 Biotronik Business Overview
10.5.5 Biotronik Recent Developments
10.6 Blue Medical
10.6.1 Blue Medical Basic Information
10.6.2 Blue Medical Drug Eluting Stents (DES) Product Overview
10.6.3 Blue Medical Drug Eluting Stents (DES) Product Market Performance
10.6.4 Blue Medical Business Overview
10.6.5 Blue Medical Recent Developments
10.7 Boston Scientific
10.7.1 Boston Scientific Basic Information
10.7.2 Boston Scientific Drug Eluting Stents (DES) Product Overview
10.7.3 Boston Scientific Drug Eluting Stents (DES) Product Market Performance
10.7.4 Boston Scientific Business Overview
10.7.5 Boston Scientific Recent Developments
10.8 DISA Vascular
10.8.1 DISA Vascular Basic Information
10.8.2 DISA Vascular Drug Eluting Stents (DES) Product Overview
10.8.3 DISA Vascular Drug Eluting Stents (DES) Product Market Performance
10.8.4 DISA Vascular Business Overview
10.8.5 DISA Vascular Recent Developments
10.9 Essen
10.9.1 Essen Basic Information
10.9.2 Essen Drug Eluting Stents (DES) Product Overview
10.9.3 Essen Drug Eluting Stents (DES) Product Market Performance
10.9.4 Essen Business Overview
10.9.5 Essen Recent Developments
10.10 Medtronic Vascular
10.10.1 Medtronic Vascular Basic Information
10.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Overview
10.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product Market Performance
10.10.4 Medtronic Vascular Business Overview
10.10.5 Medtronic Vascular Recent Developments
10.11 MicroPort Medical
10.11.1 MicroPort Medical Basic Information
10.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Overview
10.11.3 MicroPort Medical Drug Eluting Stents (DES) Product Market Performance
10.11.4 MicroPort Medical Business Overview
10.11.5 MicroPort Medical Recent Developments
10.12 MIV Therapeutics
10.12.1 MIV Therapeutics Basic Information
10.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Overview
10.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product Market Performance
10.12.4 MIV Therapeutics Business Overview
10.12.5 MIV Therapeutics Recent Developments
10.13 Orbusneich
10.13.1 Orbusneich Basic Information
10.13.2 Orbusneich Drug Eluting Stents (DES) Product Overview
10.13.3 Orbusneich Drug Eluting Stents (DES) Product Market Performance
10.13.4 Orbusneich Business Overview
10.13.5 Orbusneich Recent Developments
10.14 Promed Medical
10.14.1 Promed Medical Basic Information
10.14.2 Promed Medical Drug Eluting Stents (DES) Product Overview
10.14.3 Promed Medical Drug Eluting Stents (DES) Product Market Performance
10.14.4 Promed Medical Business Overview
10.14.5 Promed Medical Recent Developments
10.15 Relisys Medical
10.15.1 Relisys Medical Basic Information
10.15.2 Relisys Medical Drug Eluting Stents (DES) Product Overview
10.15.3 Relisys Medical Drug Eluting Stents (DES) Product Market Performance
10.15.4 Relisys Medical Business Overview
10.15.5 Relisys Medical Recent Developments
10.16 Reva Medical
10.16.1 Reva Medical Basic Information
10.16.2 Reva Medical Drug Eluting Stents (DES) Product Overview
10.16.3 Reva Medical Drug Eluting Stents (DES) Product Market Performance
10.16.4 Reva Medical Business Overview
10.16.5 Reva Medical Recent Developments
10.17 Sahajanand
10.17.1 Sahajanand Basic Information
10.17.2 Sahajanand Drug Eluting Stents (DES) Product Overview
10.17.3 Sahajanand Drug Eluting Stents (DES) Product Market Performance
10.17.4 Sahajanand Business Overview
10.17.5 Sahajanand Recent Developments
10.18 Sino Medical
10.18.1 Sino Medical Basic Information
10.18.2 Sino Medical Drug Eluting Stents (DES) Product Overview
10.18.3 Sino Medical Drug Eluting Stents (DES) Product Market Performance
10.18.4 Sino Medical Business Overview
10.18.5 Sino Medical Recent Developments
10.19 Sorin
10.19.1 Sorin Basic Information
10.19.2 Sorin Drug Eluting Stents (DES) Product Overview
10.19.3 Sorin Drug Eluting Stents (DES) Product Market Performance
10.19.4 Sorin Business Overview
10.19.5 Sorin Recent Developments
10.20 Terumo Medical
10.20.1 Terumo Medical Basic Information
10.20.2 Terumo Medical Drug Eluting Stents (DES) Product Overview
10.20.3 Terumo Medical Drug Eluting Stents (DES) Product Market Performance
10.20.4 Terumo Medical Business Overview
10.20.5 Terumo Medical Recent Developments
11 Drug Eluting Stents (DES) Market Forecast by Region
11.1 Global Drug Eluting Stents (DES) Market Size Forecast
11.2 Global Drug Eluting Stents (DES) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug Eluting Stents (DES) Market Size Forecast by Country
11.2.3 Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region
11.2.4 South America Drug Eluting Stents (DES) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drug Eluting Stents (DES) by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Drug Eluting Stents (DES) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Drug Eluting Stents (DES) by Type (2026-2033)
12.1.2 Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Drug Eluting Stents (DES) by Type (2026-2033)
12.2 Global Drug Eluting Stents (DES) Market Forecast by Application (2026-2033)
12.2.1 Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application
12.2.2 Global Drug Eluting Stents (DES) Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings